Form CORRESP - Correspondence:
SEC Accession No. 0001144204-19-046871
Filing Date
2019-10-02
Accepted
2019-10-02 11:29:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4981
  Complete submission text file 0001144204-19-046871.txt   5917
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)